Selected species of functional mushrooms in the prevention and supporting the treatment of hypertension: a narrative review
Medical Science Pulse · 06.11.2026
DOI: 10.5604/01.3001.0055.9927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Pulse, erschienen am 06.11.2026. Verfasst von Łukasz Wabiszczewicz und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Hypertension remains one of the leading causes of cardiovascular morbidity and mortality worldwide. Despite the availability of effective antihypertensive medications, blood pressure control remains suboptimal in many patients, and adverse effects associated with pharmacotherapy have stimulated interest in complementary therapeutic strategies. Functional mushrooms are a rich source of bioactive compounds capable of modulating multiple molecular pathways involved in blood pressure regulation and therefore represent promising candidates for cardiovascular prevention.
Aim of the study: This narrative review critically summarizes the current evidence regarding the antihypertensive potential of selected functional mushrooms by integrating mechanistic, in vitro, preclinical, and clinical findings. Particular emphasis is placed on the biological mechanisms underlying their activity, the quality of the available evidence, methodological limitations, and factors influencing the clinical translation of experimental findings.
Material and methods: A literature search was conducted in January 2026 using PubMed and Google Scholar. Eligible publications included mechanistic studies, in vitro experiments, animal studies, human clinical trials, and relevant review articles investigating the effects of selected functional mushrooms on blood pressure regulation and related cardiovascular pathways.
Results
Research identifies angiotensin-converting enzyme inhibition as the primary antihypertensive mechanism, with many mushroom-derived peptides (e.g., WALKGYK from T. matsutake and APPLRP from G. frondosa) acting as non-competitive or mixed-type inhibitors. Other identified mechanisms include enhancing nitric oxide bioavailability through the inhibition of arginase and acetylcholinesterase, and stimulating natriuresis via the Corin–ANP pathway. Animal studies consistently demonstrate reductions in systolic blood pressure and improvements in vascular remodeling. Human clinical evidence remains limited and inconsistent, and methodological heterogeneity together with insufficient standardization of mushroom preparations emerged as the principal barriers to clinical translation.
Conclusions
Functional mushrooms represent a promising source of bioactive compounds with potential complementary applications in hypertension management. However, current evidence is supported predominantly by mechanistic and preclinical studies, whereas robust clinical confirmation remains insufficient. Future well-designed randomized controlled trials using chemically characterized and standardized mushroom preparations are essential to establish their efficacy, safety, and potential role in evidence-based hypertension management.
Zitieren
APA
Wabiszczewicz, Ł., Filipiak, Z. M., Golińska, M., Nowak, A., Woźniak, T., Dudziak, P. M., Mróz, T., Masłowski, M., Wasilewska, N., Kita, N., & Sokołowska, A. (2026). Selected species of functional mushrooms in the prevention and supporting the treatment of hypertension: a narrative review. Medical Science Pulse. https://doi.org/10.5604/01.3001.0055.9927
Vancouver
Wabiszczewicz Ł, Filipiak ZM, Golińska M, Nowak A, Woźniak T, Dudziak PM, et al. Selected species of functional mushrooms in the prevention and supporting the treatment of hypertension: a narrative review. Medical Science Pulse. 2026. doi:10.5604/01.3001.0055.9927
BibTeX
@article{Wabiszczewicz2026,
author = {Wabiszczewicz, Łukasz and Filipiak, Zuzanna Maria and Golińska, Maria and Nowak, Anna and Woźniak, Tomasz and Dudziak, Piotr Marcin and Mróz, Tomasz and Masłowski, Marcin and Wasilewska, Natalia and Kita, Natalia and Sokołowska, Alicja},
title = {Selected species of functional mushrooms in the prevention and supporting the treatment of hypertension: a narrative review},
journal = {Medical Science Pulse},
year = {2026},
doi = {10.5604/01.3001.0055.9927}
}
EUVIMED